Davion Healthcare (DAVI) Common Equity (2024 - 2025)

Davion Healthcare's (DAVI) quarterly Common Equity came in at $74.7 million in Q4 2025, up 7.55% year-on-year from $69.4 million in Q4 2024, and up 7.55% quarter-over-quarter from $69.4 million in Q4 2024.

Davion Healthcare (DAVI) Common Equity (2024 - 2025) Analysis & Trends

Davion Healthcare has disclosed Common Equity across 2 years of filings, most recently posting $74.7 million for Q4 2025.

  • Common Equity for Q4 2025 came in at $74.7 million, up 7.55% year-over-year; the trailing twelve-month figure through Dec 2025 was $74.7 million (up 7.55% YoY), and the FY2025 annual result was $74.7 million, up 7.55% from the prior year.
  • Common Equity came in at $74.7 million for Q4 2025 at Davion Healthcare, up from $69.4 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $74.7 million in Q4 2025 to a low of $69.4 million in Q4 2024.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 74.67 Mn
Dec 31, 2024 69.42 Mn